Showing results (201-210 of 344) with videos related to
Sort By:
Pageof 35
Communications Biology|October 27, 2022
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell modelChristin Mache, Jessica Schulze, Gudrun Holland, et al.Science Advances|February 1, 2021
Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitorsChuanxiong Nie, Marlena Stadtmüller, Badri Parshad, et al.Mbio|July 26, 2018
Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A VirusAlexander Kühnl, Agnes Musiol, Nicole Heitzig, et al.Frontiers in Immunology|October 18, 2021
Beyond Vaccines: Clinical Status of Prospective COVID-19 TherapeuticsSriram Kumar, Duygu Merve Çalışkan, Josua Janowski, et al.Evolution, Medicine, and Public Health|December 20, 2021
Integrating evolutionary aspects into dual-use discussion: the cases of influenza virus and enterohemorrhagic Escherichia coliNoble Selasi Gati, Ozan Altan Altinok, Sriram Kumar, et al.European Journal of Immunology|September 11, 2002
Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytesCarsten Scheller, Sieghart Sopper, Christina Ehrhardt, et al.The Journal of Biological Chemistry|February 21, 2002
Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95Carsten Scheller, Sieghart Sopper, Peifeng Chen, et al.Journal of Virology|July 28, 2021
Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus InfectionJuliana Del Sarto, Vanessa Gerlt, Marcel Edgar Friedrich, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexesAndré Schreiber, Laurita Boff, Darisuren Anhlan, et al.Emerging Microbes & Infections|February 20, 2025
Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinibAndré Schreiber, Nicole Oberberg, Benjamin Ambrosy, et al.Pageof 35